title: Infliximab treatment for pediatric refractory Kawasaki disease.
authors.affiliation: Department of Pediatrics, Maine Medical Center, 887 Congress Street Suite 310, Portland, ME 04102, USA.
authors.forename: Laura L
authors.initials: LL
authors.lastname: Blaisdell
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Hayman
authors.forename: Adrian M
authors.initials: AM
authors.lastname: Moran
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D003323:Coronary Aneurysm / Q000175:diagnosis / Q000209:etiology; D017023:Coronary Angiography; D004305:Dose-Response Relationship, Drug; D004452:Echocardiography; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male; D009080:Mucocutaneous Lymph Node Syndrome / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab